surpass-cvot tirzepatide Diabetes Distilled: – demonstrates cardiovascular benefit in secondary prevention Inside SURPASS-CVOT With Dr. Stephen

Main effects Strong appetite suppression Reduces hunger and cravings Lowers overall calorie intake Improves blood sugar control Boosts insulin release when glucose is high Reduces excess glucose output from the liver Supports weight loss Often produces greater average weight loss than GLP-1only therapies Weight loss comes mainly from eating less (not higher calorie burn) Metabolic efficiency GIP activation may improve insulin sensitivity and tolerability Quick comparison Semaglutide GLP-1 only (appetite suppression) Tirzepatide GLP-1 + GIP (appetite + insulin synergy) Retatrutide GLP-1 + GIP + glucagon (appetite + insulin + calorie burn) What Is Tirzepatide

Devin Stone, ND Feb 1 3 min read Weight management remains a complex challenge for many people worldwide

, , .

Around 17% of patients in the four-year timeline withdrew due to a side effect of taking Wegovy, mostly nausea, according to the company